SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-22-007784
Filing Date
2022-03-25
Accepted
2022-03-25 17:30:35
Documents
19

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 2620335
2 ex2-1.htm EX-2.1 285347
3 ex23-1.htm EX-23.1 8133
4 ex2-1_001.jpg GRAPHIC 37041
5 ex2-1_002.jpg GRAPHIC 5654
6 ex23-1_001.jpg GRAPHIC 2024
7 ex23-1_002.jpg GRAPHIC 1649
8 formdrs_001.jpg GRAPHIC 6805
9 formdrs_012.jpg GRAPHIC 53780
10 formdrs_014.jpg GRAPHIC 54422
11 formdrs_002.jpg GRAPHIC 54422
12 formdrs_003.jpg GRAPHIC 11468
13 formdrs_005.jpg GRAPHIC 18507
14 formdrs_007.jpg GRAPHIC 13811
15 chart_ogd.jpg GRAPHIC 25633
16 formdrs_008.jpg GRAPHIC 12952
17 formdrs_009.jpg GRAPHIC 15165
18 image_004.jpg GRAPHIC 22461
19 formdrs_011.jpg GRAPHIC 3041
  Complete submission text file 0001493152-22-007784.txt   3383086
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-263326 | Film No.: 22772643
SIC: 2836 Biological Products, (No Diagnostic Substances)